Phillip Sherman

1.9k total citations
55 papers, 1.4k citations indexed

About

Phillip Sherman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Phillip Sherman has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Phillip Sherman's work include Neuroscience and Neuropharmacology Research (20 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Receptor Mechanisms and Signaling (8 papers). Phillip Sherman is often cited by papers focused on Neuroscience and Neuropharmacology Research (20 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Receptor Mechanisms and Signaling (8 papers). Phillip Sherman collaborates with scholars based in United States, Australia and Canada. Phillip Sherman's co-authors include Michael R. Kilbourn, Carole Quesada, Kirk A. Frey, Xia Shao, Peter J. H. Scott, Scott E. Snyder, Robert A. Koeppe, Timothy J. Desmond, David M. Raffel and David E. Kuhl and has published in prestigious journals such as ACS Nano, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Phillip Sherman

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip Sherman United States 26 543 540 313 214 213 55 1.4k
Jinsoo Hong United States 25 762 1.4× 706 1.3× 566 1.8× 320 1.5× 245 1.2× 58 2.2k
Armando García Canada 17 551 1.0× 594 1.1× 427 1.4× 190 0.9× 248 1.2× 33 1.7k
Masayuki Fujinaga Japan 23 625 1.2× 476 0.9× 389 1.2× 173 0.8× 156 0.7× 111 1.6k
Shunichi Oya United States 22 418 0.8× 519 1.0× 438 1.4× 446 2.1× 172 0.8× 41 1.5k
David Alagille United States 23 694 1.3× 601 1.1× 176 0.6× 282 1.3× 165 0.8× 87 1.7k
Robert L. Gladding United States 20 399 0.7× 347 0.6× 286 0.9× 174 0.8× 197 0.9× 46 1.3k
Christophe Plisson United Kingdom 22 558 1.0× 437 0.8× 331 1.1× 103 0.5× 168 0.8× 57 1.4k
Johan Sandell Sweden 20 380 0.7× 453 0.8× 378 1.2× 306 1.4× 124 0.6× 54 1.2k
Laurent Martarello United States 23 534 1.0× 376 0.7× 513 1.6× 114 0.5× 111 0.5× 61 1.5k
Rikki N. Waterhouse United States 20 872 1.6× 617 1.1× 278 0.9× 92 0.4× 143 0.7× 46 1.4k

Countries citing papers authored by Phillip Sherman

Since Specialization
Citations

This map shows the geographic impact of Phillip Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Sherman more than expected).

Fields of papers citing papers by Phillip Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Sherman. The network helps show where Phillip Sherman may publish in the future.

Co-authorship network of co-authors of Phillip Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Sherman. A scholar is included among the top collaborators of Phillip Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Sherman. Phillip Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drake, Lindsey, Allen F. Brooks, Phillip Sherman, et al.. (2020). Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE). Journal of Pharmaceutical Analysis. 10(5). 452–465. 11 indexed citations
2.
3.
Saccone, Phillip, Robert A. Koeppe, Xia Shao, et al.. (2016). Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception. Journal of Pharmacology and Experimental Therapeutics. 359(2). 366–373. 24 indexed citations
4.
Cole, Erin L., Xia Shao, Phillip Sherman, et al.. (2014). Synthesis and evaluation of [11C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β). Nuclear Medicine and Biology. 41(6). 507–512. 26 indexed citations
5.
Rodnick, Melissa E., Brian G. Hockley, Phillip Sherman, et al.. (2013). Novel Fluorine-18 PET Radiotracers Based on Flumazenil for GABA(A) Imaging in the Brain. PubMed Central. 12 indexed citations
6.
Raffel, David M., et al.. (2013). Quantification of Cardiac Sympathetic Nerve Density withN-11C-Guanyl-meta-Octopamine and Tracer Kinetic Analysis. Journal of Nuclear Medicine. 54(9). 1645–1652. 14 indexed citations
7.
Kilbourn, Michael R., Elizabeth R. Butch, Timothy J. Desmond, et al.. (2009). In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations. Nuclear Medicine and Biology. 37(1). 3–8. 30 indexed citations
8.
Kilbourn, Michael R., Brian G. Hockley, Lihsueh Lee, et al.. (2009). Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter. Nuclear Medicine and Biology. 36(5). 489–493. 50 indexed citations
9.
Kilbourn, Michael R., Bing Ma, Elizabeth R. Butch, Carole Quesada, & Phillip Sherman. (2007). Anesthesia increases in vivo N-([18F]fluoroethyl)piperidinyl benzilate binding to the muscarinic cholinergic receptor. Nuclear Medicine and Biology. 34(5). 479–482. 8 indexed citations
10.
Fantegrossi, William E., William L. Woolverton, Michael R. Kilbourn, et al.. (2004). Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys. Neuropsychopharmacology. 29(7). 1270–1281. 80 indexed citations
11.
Kilbourn, Michael R., Phillip Sherman, & Kyle Kuszpit. (2001). In vivo measures of dopaminergic radioligands in the rat brain: Equilibrium infusion studies. Synapse. 43(3). 188–194. 6 indexed citations
12.
Snyder, Scott E., et al.. (2000). Synthesis and in vivo evaluation of (E)-N-[11C]Methyl-4- (3-pyridinyl)-3-butene-1-amine ([11C]metanicotine) as a nicotinic receptor radioligand. Nuclear Medicine and Biology. 27(4). 415–418. 4 indexed citations
13.
Kilbourn, Michael R., Kyle Kuszpit, & Phillip Sherman. (2000). Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Synapse. 35(4). 250–255. 33 indexed citations
14.
Kilbourn, Michael R., Phillip Sherman, & Louise C. Abbott. (1998). Reduced MPTP neurotoxicity in striatum of the mutant mousetottering. Synapse. 30(2). 205–210. 39 indexed citations
15.
Snyder, Scott E., et al.. (1998). N-[11C]methylpiperidine esters as acetylcholinesterase substrates: an in vivo structure–reactivity study. Nuclear Medicine and Biology. 25(8). 755–760. 10 indexed citations
16.
Kilbourn, Michael R. & Phillip Sherman. (1997). In vivo binding of (+)-α-[3H]dihydrotetrabenazine to the vesicular monoamine transporter of rat brain: bolus vs. equilibrium studies. European Journal of Pharmacology. 331(2-3). 161–168. 15 indexed citations
17.
Snyder, Scott E., et al.. (1996). In vivo studies of acetylcholinesterase activity using a labeled substrate,N-[11C]methylpiperdin-4-yl propionate ([11C]PMP). Synapse. 22(2). 123–131. 88 indexed citations
18.
Gildersleeve, David L., Marcian E. Van Dort, Jon W. Johnson, Phillip Sherman, & Donald M. Wieland. (1996). Synthesis and Evaluation of [123I]-Iodo-PK11195 for Mapping Peripheral-Type Benzodiazepine Receptors (ω3) in Heart. Nuclear Medicine and Biology. 23(1). 23–28. 32 indexed citations
19.
Kilbourn, Michael R., Kirk A. Frey, Thierry Vander Borght, & Phillip Sherman. (1996). Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nuclear Medicine and Biology. 23(4). 467–471. 61 indexed citations
20.
Kilbourn, Michael R., Phillip Sherman, & Louise C. Abbott. (1995). Mutant mouse strains as models for in vivo radiotracer evaluations: [11C]methoxytetrabenazine ([11C]MTBZ) in Tottering mice. Nuclear Medicine and Biology. 22(5). 565–567. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinsoo Hong Breakdown of academic impact, for papers by Armando García Breakdown of academic impact, for papers by Masayuki Fujinaga Breakdown of academic impact, for papers by Shunichi Oya Breakdown of academic impact, for papers by David Alagille Breakdown of academic impact, for papers by Robert L. Gladding Breakdown of academic impact, for papers by Christophe Plisson Breakdown of academic impact, for papers by Johan Sandell Breakdown of academic impact, for papers by Laurent Martarello Breakdown of academic impact, for papers by Rikki N. Waterhouse
Rankless by CCL
2026